CNA Financial Corporation (CNA)
NYSE: CNA
· Real-Time Price · USD
46.93
-0.13 (-0.28%)
At close: Jun 05, 2025, 3:59 PM
46.97
0.09%
After-hours: Jun 05, 2025, 06:06 PM EDT
CNA Financial Revenue Breakdown
Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|---|---|
Commercial Segment Revenue | 5.22B | 4.44B | 4.2B | 3.91B | 32M | 39M |
Commercial Segment Revenue Growth | +17.56% | +5.76% | +7.31% | +12128.12% | -17.95% | n/a |
Corporate and Other Revenue | 73M | 24M | 21M | 17M | n/a | n/a |
Corporate and Other Revenue Growth | +204.17% | +14.29% | +23.53% | n/a | n/a | n/a |
International Segment Revenue | 1.28B | 1.13B | 1.11B | 998M | n/a | n/a |
International Segment Revenue Growth | +12.79% | +1.80% | +11.62% | n/a | n/a | n/a |
Life and Group Non-Core Segment Revenue | 1.35B | 1.28B | 1.46B | 1.35B | n/a | n/a |
Life and Group Non-Core Segment Revenue Growth | +5.49% | -12.42% | +7.53% | n/a | n/a | n/a |
Specialty Segment Revenue | 5.49B | 5.21B | 5B | 4.58B | n/a | n/a |
Specialty Segment Revenue Growth | +5.39% | +4.10% | +9.14% | n/a | n/a | n/a |
Revenue by Geography
Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Specialty Segment Revenue | 5.49B | 1.79B | 1.62B | 1.41B |
Specialty Segment Revenue Growth | +207.39% | +9.98% | +15.01% | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling, General, and Administrative Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |